Pleas to Lawmakers Have Had an Impact

Perhaps our pleas to lawmakers have had an impact.

Please contact your local representatives so they can put some pressure to get this bill approved.

The goal of this bill (S. 2260) is to expand, intensify, and coordinate fundamental, translational, and clinical research capabilities of the National Institutes of Health with respect to opioid abuse, the understanding of pain, and the discovery and development of safer and more effective treatments and preventive interventions for pain. ”

This is a 5 year, $5 Billion (with a B) initiative that supports the following:

1. directs the National Institutes of Health to intensify and coordinate fundamental, translational, and clinical research with respect to

(A) the understanding of pain;

(B) the discovery and development of therapies for chronic pain; and

(C) the development of alternatives to opioids for effective pain treatments.

2. Developing improved options and evidence for medication-assisted treatment.

3. Developing improved options and evidence for opioid overdose reversal treatments.

4. The Federal Pain Research Strategy, including research that focuses on—

(A) novel drugs, non-addictive, and non-pharmacological treatments for pain;

(B) screening tools and outcome measures for assessments across the continuum of pain;

(C) national registries, datasets, and research networks;

(D) effective models of care delivery for pain management; and

(E) precision medicine methodology to prevent and treat pain.

5. The components of the Department of Health and Human Services five-point strategy to address the opioid crisis that states: “Providing support for cutting edge research on pain and addiction”.

6. The pain therapy screening program established under section 4.

7. Other elements that the Secretary of Health and Human Services may designate, in consultation with the Director of the National Institutes of Health.

Hopefully we can get enough support to get this bill approved!

https://www.congress.gov/…/115th-cong…/senate-bill/2260/text

Facebook
Twitter
LinkedIn
Pinterest
About President, CEO & Board Member

Mr. Crossman is responsible for the overall management of the Company and the creation, planning and execution of business and financial strategies and corporate development activities, including capital generation.

Get fresh updates
about my life in your inbox

Mr. Crossman is responsible for the overall management of the Company and the creation, planning and execution of business and financial strategies and corporate development activities, including capital generation.
Crossman is a senior management professional with international and domestic experience as CEO, COO and CFO of enterprises ranging from entrepreneurial start-ups to Fortune 500 level companies. He has a proven track record of successfully commercializing various emerging technologies including manufacturing and industrial systems, computer software, marine bioremediation, nanotechnology and life sciences.

Mr.Crossman has assisted numerous early-stage companies to refine business strategies, commercialize new products, raise capital, license technologies, scale revenues and production, and expand into global markets. As CEO of ISOPur Fluid Technologies, Crossman led the company from product introduction to global growth with expanding applications in multiple vertical markets. Important strategic alliances were developed with Siemens, BHP, Atlas Copco, Hess, Sanwa Shoko and others, creating a platform for continued strong growth.

The value of the founding shareholders’ common stock increased more than tenfold in less than three years under Crossman’s leadership. As CFO of Otis Elevator Company – Asia Pacific Operations, Crossman evaluated, negotiated and developed acquisitions, joint ventures and major capital investments in China, Japan, Korea, India, Southeast Asia, and Australia. Mr. Crossman contributed to profit growth of 20% per year and market share gains of 1% per year in this mature multi-billion dollar operation spanning 23 countries, despite aggressive competition from large Asian conglomerates. The joint ventures that he helped developed in China are among the most profitable operations of United Technologies Corp today. Bill holds a BS degree from the U.S. Merchant Marine Academy at Kings Point and a MBA from the Haas School of Business at the University of California – Berkeley.